Literature DB >> 7502037

Epidemiology. China's unique environment favors large intervention trials.

J Mervis.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7502037     DOI: 10.1126/science.270.5239.1149

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Scientific publications in urology and nephrology journals from China: A 10-year analysis.

Authors:  Xiaomei Zhou; Changyong Xing; Lei Xin; Hongzhen Hu; Liping Li; Jingchuan Fang; Zhiyong Liu
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

2.  Report of China's innovation increase and research growth in radiation oncology.

Authors:  Hongcheng Zhu; Xi Yang; Qin Qin; Kangqi Bian; Chi Zhang; Jia Liu; Hongyan Cheng; Xinchen Sun
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

3.  Bibliometric analysis of scientific publications in transplantation journals from Mainland China, Japan, South Korea and Taiwan between 2006 and 2015.

Authors:  Qiang-Hong Pu; Qiu-Ju Lyu; Huai-Yu Su
Journal:  BMJ Open       Date:  2016-08-03       Impact factor: 2.692

4.  miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.

Authors:  Guangyuan Song; Hongcheng Zhang; Chenlin Chen; Lijie Gong; Biao Chen; Shaoyun Zhao; Ji Shi; Ji Xu; Zaiyuan Ye
Journal:  Oncotarget       Date:  2017-07-11

5.  Scientific publications in respiratory journals from Chinese authors in various parts of North Asia: a 10-year survey of literature.

Authors:  Bo Ye; Ting-Ting Du; Ting Xie; Jun-Tao Ji; Zhao-Hong Zheng; Zhuan Liao; Liang-Hao Hu; Zhao-Shen Li
Journal:  BMJ Open       Date:  2014-02-28       Impact factor: 2.692

6.  The current state of cardiology in China.

Authors:  Tsung O Cheng
Journal:  Int J Cardiol       Date:  2004-09       Impact factor: 4.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.